ERIC CAMYRE: Open Payments
NPI 1831326461 · VERNON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,068 in 192 payments from 33 companies in 2025. Trend: 2023 $3,742 · 2024 $4,201 · 2025 $4,068
Food & beverage: $4,068
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $427 |
| ABBVIE INC. | 28 | $406 |
| Novo Nordisk Inc | 12 | $292 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $289 |
| PFIZER INC. | 11 | $257 |
| GlaxoSmithKline, LLC. | 12 | $255 |
| Lundbeck LLC | 14 | $188 |
| Phathom Pharmaceuticals, Inc. | 5 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $145 |
| Lilly USA, LLC | 7 | $139 |
Products named: REXULTI, JARDIANCE, TRELEGY ELLIPTA, VRAYLAR, AIRSUPRA, NURTEC ODT, VOQUEZNA, CAPLYTA.
Industry payments across CT — which companies pay providers there.
